TrialFind
Saved trials
Back to results
Withdrawn
Phase 2
Improving Beta-2 Adrenergic Signaling in Alzheimer's Disease
NCT02500784
What is this trial?
Generating plain-language summary...
Am I eligible?
Generating eligibility summary...
What's involved?
Summarizing study design...
Where and how to apply
Primary location
VA Palo Alto Health Care System
Palo Alto, California, United States
View on ClinicalTrials.gov
Official details
Improving Beta-2 Adrenergic Signaling in Alzheimer's Disease — TrialFind